PFIZER INC

PFE
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000078003

Price chart

Open-market purchases and sales by PFE insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 12, 20264:04 PM ETAug 12, 2026BOURLA ALBERTChairman & CEOPPurchaseCommon Stock+38K$26.34+$1M429.17K+9.7%SEC
Aug 6, 202611:26 AM ETAug 5, 2026DAMICO JENNIFER B.SVP & ControllerSSaleCommon Stock−3.28K$25.40−$83.26K28.61K−10.3%SEC
Aug 5, 20264:03 PM ETAug 5, 2026BLAYLOCK RONALD EDirectorPPurchaseCommon Stock+39.23K$25.46+$998.82K66.94K+141.6%SEC
Aug 5, 20264:02 PM ETAug 5, 2026Buckley Mortimer JDirectorPPurchaseCommon Stock+37.63K$25.52+$960.37K37.63KNew positionSEC
Jun 10, 2026Jun 9, 2026DAMICO JENNIFER B.SVP & ControllerSSaleCommon Stock−2K$25.70−$51.4K31.4K−6.0%SEC

The largest institutional positions in PFE at the end of Q2 2026.

Institutions holding PFE in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.529,670,433$12.75B0.19%+31,412,883+6.3%Added
VANGUARD CAPITAL MANAGEMENT LLC372,149,852$8.96B0.19%+2,719,840+0.7%Added
STATE STREET CORP307,090,897$7.39B0.22%+5,501,032+1.8%Added
GEODE CAPITAL MANAGEMENT, LLC135,275,782$3.25B0.17%+1,714,040+1.3%Added
VANGUARD PORTFOLIO MANAGEMENT LLC119,235,030$2.87B0.13%+2,500,335+2.1%Added